ReviewTherapeutic advances in respiratory disease

Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases.

Pascale Tomasini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.